| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 

BeiGene doses first patient in phase 1b/2 trial of ZW25 in HER2-positive breast cancer and GEA Comments List

Positive
0% 0
/Neutral
0% 0
Negative
0% 0
Back to TOP
       Anonymous     (Enter between5to500characters)

                                 Current: 0words
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028